HOLLY NICHOLS: Open Payments
NPI 1245800176 · PELL CITY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$348 in 17 payments from 12 companies in 2025. Trend: 2023 $812 · 2024 $1,009 · 2025 $348
Food & beverage: $348
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 2 | $51 |
| GlaxoSmithKline, LLC. | 2 | $47 |
| Novo Nordisk Inc | 2 | $42 |
| ABBVIE INC. | 2 | $40 |
| PFIZER INC. | 2 | $32 |
| Verona Pharma, Inc. | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Medtronic, Inc. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
Products named: Auvelity, TRELEGY ELLIPTA, Ozempic, VRAYLAR, Ohtuvayre, AIRSUPRA, GEMTESA, VENASEAL.
Industry payments across AL — which companies pay providers there.
